These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25891210)

  • 41. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pitavastatin - from clinical trials to clinical practice.
    Masana L
    Atheroscler Suppl; 2010 Dec; 11(3):15-22. PubMed ID: 21193154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER).
    Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N
    J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J
    Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Statin Therapy in 4-Year-Old Dichorionic Diamniotic Twins with Familial Hypercholesterolemia Showing Multiple Xanthomas.
    Miyagi Y; Harada-Shiba M; Ohta T
    J Atheroscler Thromb; 2016; 23(1):112-7. PubMed ID: 26510755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals.
    Saito Y
    Vasc Health Risk Manag; 2009; 5():921-36. PubMed ID: 19997573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia.
    Poolsup N; Suksomboon N; Wongyaowarat K; Rungkanchananon B; Niyomrat P; Kongsuwan S
    J Clin Pharm Ther; 2012 Apr; 37(2):166-72. PubMed ID: 21585411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia.
    Knipscheer HC; Boelen CC; Kastelein JJ; van Diermen DE; Groenemeijer BE; van den Ende A; Büller HR; Bakker HD
    Pediatr Res; 1996 May; 39(5):867-71. PubMed ID: 8726243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.
    Stein EA; Dufour R; Gagne C; Gaudet D; East C; Donovan JM; Chin W; Tribble DL; McGowan M
    Circulation; 2012 Nov; 126(19):2283-92. PubMed ID: 23060426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Multicenter Prospective Hospital-based Cohort Study on the Efficacy and Safety of Pitavastatin.
    Shehab A; Elnour AA; Bhagavathula AS; Kurian JP; Hassan G; AlZaabi S; Gilbert H; Al-Rasadi K
    Curr Diabetes Rev; 2021; 17(7):e122820189541. PubMed ID: 33371852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.
    Avis HJ; Hutten BA; Gagné C; Langslet G; McCrindle BW; Wiegman A; Hsia J; Kastelein JJ; Stein EA
    J Am Coll Cardiol; 2010 Mar; 55(11):1121-6. PubMed ID: 20223367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
    Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
    Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison.
    Saito Y; Yamada N; Teramoto T; Itakura H; Hata Y; Nakaya N; Mabuchi H; Tushima M; Sasaki J; Goto Y; Ogawa N
    Arzneimittelforschung; 2002; 52(4):251-5. PubMed ID: 12040967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia.
    Teramoto T; Shimano H; Yokote K; Urashima M
    J Atheroscler Thromb; 2009 Oct; 16(5):654-61. PubMed ID: 19907105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The efficacy and safety of pitavastatin].
    Sansoy V
    Turk Kardiyol Dern Ars; 2017 Apr; 45(Suppl 3):1-4. PubMed ID: 28952470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of efficacy of intensive versus mild pitavastatin therapy on lipid and inflammation biomarkers in hypertensive patients with dyslipidemia.
    Yamasaki T; Iwashima Y; Jesmin S; Ohta Y; Kusunoki H; Hayashi S; Horio T; Kawano Y
    PLoS One; 2014; 9(2):e89057. PubMed ID: 24586502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C.
    Teramoto T
    Expert Opin Pharmacother; 2012 Apr; 13(6):859-65. PubMed ID: 22332608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.
    Stein EA; Amerena J; Ballantyne CM; Brice E; Farnier M; Guthrie RM; Harats D; Ma PT; Le Maulf F; Melezínková H; Gold A; Sager P
    Am J Cardiol; 2007 Nov; 100(9):1387-96. PubMed ID: 17950795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.